Horizon Therapeutics Public Ltd Co

MORGAN STANLEY

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/15/2023

Shares

2,839,854

Value ($000)

328,543

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/15/2023	328,543	0.0%	2,839,854	9/30/2023
2023 Q2	8/14/2023	308,750	0.0%	3,001,949	6/30/2023
2023 Q1	5/15/2023	231,378	0.0%	2,120,014	3/31/2023
2022 Q4	2/14/2023	170,858	0.0%	1,501,384	12/31/2022
2022 Q3	11/14/2022	105,423	0.0%	1,703,380	9/30/2022
2022 Q2	10/27/2022	109,352	0.0%	1,371,016	6/30/2022
2022 Q1	10/27/2022	132,634	0.0%	1,260,653	3/31/2022
2021 Q4	2/14/2022	151,688	0.0%	1,407,648	12/31/2021
2021 Q3	11/15/2021	138,419	0.0%	1,263,648	9/30/2021
2021 Q2	8/23/2021	70,572	0.0%	753,642	6/30/2021
2021 Q1	5/17/2021	62,365	0.0%	677,581	3/31/2021
2020 Q4	2/16/2021	56,026	0.0%	765,899	12/31/2020
2020 Q3	11/13/2020	67,540	0.0%	869,471	9/30/2020
2020 Q2	8/14/2020	21,292	0.0%	383,086	6/30/2020
2020 Q1	5/26/2020	10,349	0.0%	349,358	3/31/2020
2019 Q4	2/14/2020	11,692	0.0%	322,973	12/31/2019